NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings
4 - Himmelreich Jeffrey C
Filed:
2026-04-14
AccNo:
0001878313-26-000044
Size:
5 KB
发布时间04/14 12:42 UTC
首次发现04/14 12:43 UTC
热度106.3
重要度74
情绪0.00
站内整理正文
优先显示结构化正文；如果正文还未抽出，则回退到摘要。
sec_edgar_index_v1 · 497 字符
Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001878313-26-000044
Filing Date: 2026-04-14
Accepted: 2026-04-14 08:42:09
Documents: 1
Period of Report: 2026-04-10
MAIA Biotechnology, Inc. ( Issuer ) CIK : 0001878313 (see all company filings) EIN. : 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)
1 | PRIMARY DOCUMENT | form4.html | 4
1 | PRIMARY DOCUMENT | form4.xml | 4